日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA

纳武利尤单抗联合伊匹木单抗和化疗作为转移性非小细胞肺癌患者一线治疗方案:CheckMate 9LA 研究的最终 6 年结果

Carbone, D P; Ciuleanu, T-E; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Felip, E; Cheng, Y; Juan-Vidal, O; Alexandru, A; Mizutani, H; Reinmuth, N; Lu, S; Reck, M; John, T; Scherpereel, A; De Marchi, P; Aoyama, T; Sathyanarayana, P; Grootendorst, D J; Hu, N; Ip, V; Hung, Y-H; Paz-Ares, L G

The miRNA-immune axis in bladder cancer: systematic evidence for a new era of immunotherapy precision

膀胱癌中的miRNA-免疫轴:免疫治疗精准治疗新时代的系统性证据

Dulf, Daniel-Vasile; Ravegnini, Gloria; Giorgi, Federico Manuel; Burnar, Anamaria Larisa; Gorini, Francesca; De Leo, Antonio; Luţichievici, Harisa; Opriţa, Constantin-Lucian; Todiruţ, Cezar-Nicolae; Ciuleanu, Tudor-Eliade; Coadă, Camelia Alexandra

The Genomic Landscape of Romanian Non-Small Cell Lung Cancer Patients: The Insights from Routine NGS Testing with the Oncomine Dx Target Panel at the PATHOS Molecular Pathology Laboratory

罗马尼亚非小细胞肺癌患者的基因组图谱:PATHOS分子病理实验室使用Oncomine Dx Target Panel进行常规NGS检测的启示

Gaal, Orsolya I; Ungureanu, Andrei; Pop, Bogdan; Tomescu, Andreea; Cătană, Andreea; Man, Milena; Râjnoveanu, Ruxandra Mioara; Palade, Emanuel; Simon, Marioara; Luchian, Stefan Dan; Kubelac, Milan Paul; Fulop, Annamaria; Fekete, Zsolt; Ciuleanu, Tudor Eliade; Jentimir, Ion; Popovici, Bogdan; Cainap, Calin; Preda, Alexandra Cristina; Magdau, Cosmina; Lesan, Andrei; Fetica, Bogdan

Chemo-Radio-Immunotherapy Strategies to Prevent Immune Resistance in Non-Small Cell Lung Cancer

化疗-放疗-免疫疗法策略预防非小细胞肺癌的免疫耐药性

Rusu-Patraulea, Renata-Andrea; Rusu, Petronela; Ciuleanu, Tudor-Eliade

Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study

Xevinapant联合avelumab治疗晚期实体瘤,并在晚期非小细胞肺癌中进行剂量扩展:一项开放标签、非随机Ib期研究的探索性生物标志物、安全性和疗效分析

Goss, Glenwood; Ciuleanu, Tudor; Ramlau, Rodryg; Renouf, Daniel J; Chu, Quincy; Kalinka, Ewa; Sawrycki, Piotr; Bramson, Jonathan; Nelson, Brad H; Crabbé, Rafael; LaCasse, Eric; Lo, Bryan; Sahlender, Daniela A; Crompton, Philippa; Brichory, Franck; Piggott, Luke; Schenker, Michael; Juergens, Rosalyn

Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center

抗PD-1治疗下非小细胞肺癌和黑色素瘤患者血清TNF-α、IL-10和IL-2水平变化轨迹及预后:来自单中心的纵向真实世界证据

Grecea-Balaj, Alina Miruna; Soritau, Olga; Brie, Ioana; Perde-Schrepler, Maria; Virag, Piroska; Fischer-Fodor, Eva; Todor, Nicolae; Cenariu, Mihai; Nedelea, Ioana; Ciuleanu, Tudor Eliade

Lymphovascular Invasion Is a Predictor of Clinical Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy

淋巴血管侵犯是接受根治性膀胱切除术治疗的膀胱癌患者临床结局的预测因子

Dulf, Daniel-Vasile; Burnar, Anamaria Larisa; Dulf, Patricia-Lorena; Matei, Doina-Ramona; Hendea, Raluca Maria; Andraș, Iulia; Grecea, Miruna; Bungărdean, Cătălina; De Leo, Antonio; Ciuleanu, Tudor-Eliade; Crișan, Nicolae; Coada, Camelia Alexandra

Risk Stratification Using a Perioperative Nomogram for Predicting the Mortality of Bladder Cancer Patients Undergoing Radical Cystectomy

利用围手术期列线图进行风险分层,预测接受根治性膀胱切除术的膀胱癌患者的死亡率

Dulf, Daniel-Vasile; Burnar, Anamaria Larisa; Dulf, Patricia-Lorena; Matei, Doina-Ramona; Maria, Hendea Raluca; Bungărdean, Cătălina; Buzoianu, Maximilian; Andraș, Iulia; Ciuleanu, Tudor-Eliade; Crișan, Nicolae; Coadă, Camelia Alexandra

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

在 II 期 LUMINOSITY 试验中,Telisotuzumab Vedotin 单药治疗既往接受过治疗的 c-Met 蛋白过表达的晚期非鳞状 EGFR 野生型非小细胞肺癌患者

Camidge, D Ross; Bar, Jair; Horinouchi, Hidehito; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan; Ciuleanu, Tudor; Daaboul, Nathalie; Liu, Chunling; Bradbury, Penelope; Moskovitz, Mor; Katgi, Nuran; Tomasini, Pascale; Zer, Alona; Girard, Nicolas; Cuppens, Kristof; Han, Ji-Youn; Wu, Shang-Yin; Baijal, Shobhit; Mansfield, Aaron S; Kuo, Chih-Hsi; Nishino, Kazumi; Lee, Se-Hoon; Planchard, David; Baik, Christina; Li, Martha; Ansell, Peter; Xia, Summer; Bolotin, Ellen; Looman, Jim; Ratajczak, Christine; Lu, Shun

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial

CheckMate 9LA随机试验中,一线纳武利尤单抗联合伊匹木单抗和化疗治疗转移性非小细胞肺癌的四年临床更新和治疗转换调整后的结果

Carbone, David P; Ciuleanu, Tudor-Eliade; Schenker, Michael; Cobo, Manuel; Bordenave, Stéphanie; Juan-Vidal, Oscar; Menezes, Juliana; Reinmuth, Niels; Richardet, Eduardo; Cheng, Ying; Mizutani, Hideaki; Felip, Enriqueta; Zurawski, Bogdan; Alexandru, Aurelia; Paz-Ares, Luis; Lu, Shun; John, Thomas; Zhang, Xiaoqing; Mahmood, Javed; Hu, Nan; De, Tuli; Santi, Irene; Penrod, John R; Yuan, Yong; Lee, Adam; Reck, Martin